Clinical Trial Update: Effectiveness and Safety of Adding Bevacizumab to First Line Chemotherapy in Lung Cancer Patients With Stable Disease [Phase 2]

View source ↗

Summary

This phase 2 clinical trial update evaluates the effectiveness and safety of adding bevacizumab to first-line chemotherapy in patients with metastatic non-small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Beijing Hospital | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: UNKNOWN